AMZN
Amazon.com, Inc.
AMZN has the edge over BSET overall, supported by stronger valuation and stronger fundamentals.
BSET
Bassett Furniture Industries, Incorporated
BSET's outlook is improving despite an expensive valuation.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BSET Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
BSET's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BSET in the historical PE scenario, which offers more potential upside but is not a forecast.
BSET PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 2.7x | $2.16 | -90% |
| Fair | 10x | $8.25 | -62% |
| Forward | 19x | $21.59 | — |
| Current | 27x | $21.59 | — |
| Expensive | 28x | $21.83 | +1.1% |
Historical ranges are pointers, not guarantees.
BSET's PE is in its expensive range at 27x. If earnings grow as analysts expect, today's price would be 19x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BSET Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect BSET's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BSET on earnings, with more consistent year-over-year improvement.
BSET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.15 | +46% |
| Q3 2026 | $0.79 | -11% |
| Q2 2026 | $0.64 | +129% |
| Q1 2026 | $0.62 | +$1.38 |
| Q4 2025 | $0.70 | +$1.81 |
| Q3 2025 | $0.89 | +$2.83 |
| Q2 2025 | $0.28 | +$2.00 |
| Q1 2025 | -$0.76 | -$0.10 |
| Q4 2024 | -$1.11 | -$0.75 |
BSET's earnings per share have fallen from their peak: $0.79 over the past year, against $6.96 in late 2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BSET on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BSET on profitability, with a higher operating margin.
BSET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.8M | +3.4% |
| Q2 2026 | $83.8M | -0.7% |
| Q1 2026 | $80.3M | -2.2% |
| Q4 2025 | $88.7M | +5.1% |
| Q3 2025 | $80.1M | +5.9% |
| Q2 2025 | $84.3M | +1.1% |
| Q1 2025 | $82.2M | -5.1% |
| Q4 2024 | $84.3M | -11% |
BSET's revenue fell from its 2021 peak and has held roughly level since: $83M last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.4% | +2.6 points |
| Q2 2026 | 2.7% | -0.3 points |
| Q1 2026 | 1.4% | -1.6 points |
| Q4 2025 | 2.6% | +1.5 points |
| Q3 2025 | 0.7% | +9.2 points |
| Q2 2025 | 3% | +13 points |
| Q1 2025 | 3% | +5.7 points |
| Q4 2024 | 1.1% | +5.8 points |
BSET's operating margin was 3.4% last quarter, up 2.6 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BSET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.8M | +$4.5M |
| Q2 2026 | $5.6M | +1.5% |
| Q1 2026 | -$6.3M | -$5.4M |
| Q4 2025 | $7M | +19% |
| Q3 2025 | -$2.6M | -$1.2M |
| Q2 2025 | $5.6M | +32% |
| Q1 2025 | -$923K | +$8.9M |
| Q4 2024 | $5.9M | +4.2% |
BSET has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BSET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +2.8K shares |
| 1 year | -0.4% | -36.1K shares |
| 3 years | -1.1% | -97K shares |
| 5 years | -12% | -1.1M shares |
| Available history | -16% | -1.6M shares |
BSET has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $126,000 |
| Q2 2026 | $506,000 |
| Q1 2026 | $147,000 |
| Q4 2025 | $628,000 |
| Q3 2025 | $364,000 |
| Q2 2025 | $437,000 |
| Q1 2025 | $721,000 |
| Q4 2024 | $293,000 |
BSET spent $1M buying back its own shares over the past year, down 22% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BSET Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.0x | Net Cash |
| Q2 2026 | -2.4x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -2.5x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -4.6x | Net Cash |
| Q1 2024 | -17.9x | Net Cash |
| Q4 2023 | -7.5x | Net Cash |
BSET has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BSET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.9 | Neutral |
| Stochastic | 78.5 | Neutral |
BSET's weekly RSI is 63 (neutral) and its Stochastic is 79 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over BSET on valuation relative to its sector.
BSET PE vs Consumer Cyclical Sector
| Metric | BSET | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 18x | 52% above |
| PE % | 82 | 47 | 35 pts above |
BSET is trading at 27x earnings, a 52% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
BSET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 2% above |
| 20 week MA | $20.1 | 7.4% above |
| 50 week MA | $17.3 | 25% above |
| 100 week MA | $16.5 | 31% above |
| 200 week MA | $15.9 | 36% above |
BSET is in an uptrend: it's above all five of its weekly moving averages, and 36% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
BSET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.8 | $19.9 | +18% |
| 2021 | $19.9 | $16.6 | -17% |
| 2022 | $16.6 | $17.1 | +3.1% |
| 2023 | $17.1 | $16.6 | -2.8% |
| 2024 | $16.6 | $13.9 | -17% |
| 2025 | $13.9 | $17.1 | +24% |
| 2026 YTD | $17.1 | $21.6 | +26% |
BSET has the edge over AMZN on returns for 2026, with the stronger performance.